These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30015488)

  • 21. Chemogenomics approaches to G-protein coupled receptor lead finding.
    Klabunde T; Jäger R
    Ernst Schering Res Found Workshop; 2006; (58):31-46. PubMed ID: 16708997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.
    Hanke S; Tindall CA; Pippel J; Ulbricht D; Pirotte B; Reboud-Ravaux M; Heiker JT; Sträter N
    J Med Chem; 2020 Jun; 63(11):5723-5733. PubMed ID: 32374603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and antitumor activity evaluation of Chrysamide B derivatives.
    Zhu L; Li J; Fan X; Hu X; Chen J; Liu Y; Hao X; Shi T; Wang Z; Zhao Q
    Bioorg Chem; 2021 Jun; 111():104828. PubMed ID: 33895605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering.
    Sananes A; Cohen I; Shahar A; Hockla A; De Vita E; Miller AK; Radisky ES; Papo N
    J Biol Chem; 2018 Aug; 293(33):12663-12680. PubMed ID: 29934309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors.
    Sun DX; Liu L; Heinz B; Kolykhalov A; Lamar J; Johnson RB; Wang QM; Yip Y; Chen SH
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4333-8. PubMed ID: 15261297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel hydroxyamides and amides containing D-glucopyranose or D-fructose units: Biological assays in MCF-7 and MDST8 cell lines.
    Carreiro EP; Costa AR; Cordeiro MM; Martins R; Pires TO; Saraiva M; Antunes CM; Burke AJ
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1039-1043. PubMed ID: 26725029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformationally biased P3 amide replacements of beta-secretase inhibitors.
    Stachel SJ; Coburn CA; Steele TG; Crouthamel MC; Pietrak BL; Lai MT; Holloway MK; Munshi SK; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2006 Feb; 16(3):641-4. PubMed ID: 16263281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Kallikrein 7 in Tumorigenesis.
    Xiang F; Wang Y; Cao C; Li Q; Deng H; Zheng J; Liu X; Tan X
    Curr Med Chem; 2022; 29(15):2617-2631. PubMed ID: 34525904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.
    Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2017 Feb; 127():41-61. PubMed ID: 28038326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.
    Lyu C; Ye Y; Lensing MM; Wagner KU; Weigel RJ; Chen S
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34343132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designed Parasite-Selective Rhomboid Inhibitors Block Invasion and Clear Blood-Stage Malaria.
    Gandhi S; Baker RP; Cho S; Stanchev S; Strisovsky K; Urban S
    Cell Chem Biol; 2020 Nov; 27(11):1410-1424.e6. PubMed ID: 32888502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-quantitative structure-activity relationship study for the design of novel enterovirus A71 3C protease inhibitors.
    Nie Q; Xu X; Zhang Q; Ma Y; Yin Z; Shang L
    Chem Biol Drug Des; 2018 Oct; 92(4):1750-1762. PubMed ID: 29877617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.
    Kwan JC; Eksioglu EA; Liu C; Paul VJ; Luesch H
    J Med Chem; 2009 Sep; 52(18):5732-47. PubMed ID: 19715320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.
    Yu Y; Prassas I; Dimitromanolakis A; Diamandis EP
    J Biol Chem; 2015 Jul; 290(29):17762-17775. PubMed ID: 26032414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity.
    Elsadek LA; Ellis EK; Seabra G; Paul VJ; Luesch H
    Mar Drugs; 2023 Dec; 22(1):. PubMed ID: 38248654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and evaluation of novel indirubin-based N-hydroxybenzamides, N-hydroxypropenamides and N-hydroxyheptanamides as histone deacetylase inhibitors and antitumor agents.
    Anh DT; Hai PT; Dung DTM; Dung PTP; Huong LT; Park EJ; Jun HW; Kang JS; Kwon JH; Tung TT; Han SB; Nam NH
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127537. PubMed ID: 32916298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
    Karnezis T; Farnsworth RH; Harris NC; Williams SP; Caesar C; Byrne DJ; Herle P; Macheda ML; Shayan R; Zhang YF; Yazar S; Takouridis SJ; Gerard C; Fox SB; Achen MG; Stacker SA
    Cancer Res; 2019 Apr; 79(7):1558-1572. PubMed ID: 30709930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.